Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-04-008736
Filing Date
2004-03-29
Accepted
2004-03-29 17:20:34
Documents
12
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a04-3795_110k.htm 10-K 1514340
3 EX-4.1 a04-3795_1ex4d1.htm EX-4.1 110423
4 EX-10.152 a04-3795_1ex10d152.htm EX-10.152 67211
5 EX-10.153 a04-3795_1ex10d153.htm EX-10.153 72635
6 EX-10.154 a04-3795_1ex10d154.htm EX-10.154 5701
7 EX-14.1 a04-3795_1ex14d1.htm EX-14.1 30412
8 EX-21.1 a04-3795_1ex21d1.htm EX-21.1 1542
9 EX-23.1 a04-3795_1ex23d1.htm EX-23.1 4698
10 EX-31.1 a04-3795_1ex31d1.htm EX-31.1 9763
11 EX-31.2 a04-3795_1ex31d2.htm EX-31.2 9853
12 EX-32.1 a04-3795_1ex32d1.htm EX-32.1 4978
13 EX-32.2 a04-3795_1ex32d2.htm EX-32.2 6336
  Complete submission text file 0001104659-04-008736.txt   1840660
Mailing Address 5931 DARWIN COURT CARLSBAD CA 92008
Business Address 5931 DARWIN COURT CARLSBAD CA 92008 7604317080
IMMUNE RESPONSE CORP (Filer) CIK: 0000817785 (see all company filings)

EIN.: 330255679 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-18006 | Film No.: 04697192
SIC: 2836 Biological Products, (No Diagnostic Substances)